Nektar Therapeutics (NKTR)

NASDAQ: NKTR · Real-Time Price · USD

41.17

+0.37 (0.91%)

Oct 9, 2026, 4:00 PM EDT - Market closed

Nektar Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	54.59	55.23	98.43	90.12	92.06	101.91
Revenue Growth	-27.15%	-43.89%	9.21%	-2.10%	-9.67%	-33.36%
Gross Profit	54.59	55.23	67.74	56.35	70.42	77.01
Operating Income	-130.64	-130.77	-129.92	-135.23	-240.24	-446.1
Net Income	-157.13	-164.08	-118.96	-276.06	-368.2	-523.84
Earnings Per Share	-6.47	-9.73	-8.68	-21.79	-29.55	-42.90
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	-	1.38	11.48	9.84	10.11
Rest of World	55.23	97.05	78.64	82.21	91.79
Total	55.23	98.43	90.12	92.06	101.91

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	684.34	245.75	269.1	329.44	504.98	798.78
Total Debt	135.93	148.91	194.34	230.4	286.87	338.6
Net Cash (Debt)	548.41	96.84	74.76	99.04	218.1	460.18
Net Cash Growth	-	29.55%	-24.52%	-54.59%	-52.61%	-45.73%
Net Cash Per Share	22.57	5.74	5.45	7.82	17.48	37.66

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-233.79	-208.51	-175.71	-192.61	-304.01	-412.66
Capital Expenditures	-0.94	-0.87	-1.47	-0.87	-5.68	-14.99
Free Cash Flow	-234.73	-209.38	-177.18	-193.47	-309.68	-427.65
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	100.00%	100.00%	68.82%	62.53%	76.50%	75.57%
Operating Margin	-239.32%	-236.77%	-131.99%	-150.05%	-260.97%	-437.76%
Pretax Margin	-287.72%	-297.32%	-121.10%	-306.54%	-396.48%	-513.49%
Profit Margin	-287.84%	-297.07%	-120.86%	-306.31%	-399.98%	-514.03%
FCF Margin	-429.99%	-379.09%	-180.01%	-214.68%	-336.41%	-419.65%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	15.88	15.88	15.88	15.88	15.88
PS Ratio	25.75	15.57	1.74	1.20	4.61	24.47